Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,095,569
  • Shares Outstanding, K 47,059
  • Annual Sales, $ 2,328 M
  • Annual Income, $ 984,800 K
  • 60-Month Beta 0.52
  • Price/Sales 4.81
  • Price/Cash Flow 10.78
  • Price/Book 1.87
Trade UTHR with:

Options Overview Details

View History
  • Implied Volatility 30.47% ( -0.85%)
  • Historical Volatility 25.07%
  • IV Percentile 75%
  • IV Rank 59.03%
  • IV High 37.54% on 05/02/23
  • IV Low 20.29% on 09/15/23
  • Put/Call Vol Ratio 2.41
  • Today's Volume 58
  • Volume Avg (30-Day) 215
  • Put/Call OI Ratio 2.04
  • Today's Open Interest 5,336
  • Open Int (30-Day) 4,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 5.62
  • Number of Estimates 9
  • High Estimate 6.54
  • Low Estimate 4.75
  • Prior Year 4.86
  • Growth Rate Est. (year over year) +15.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
213.75 +9.46%
on 02/20/24
250.36 -6.55%
on 03/12/24
+19.24 (+8.96%)
since 02/16/24
3-Month
208.62 +12.15%
on 02/08/24
250.36 -6.55%
on 03/12/24
-12.43 (-5.04%)
since 12/18/23
52-Week
204.44 +14.44%
on 05/30/23
261.54 -10.54%
on 08/02/23
+14.24 (+6.48%)
since 03/17/23

Most Recent Stories

More News
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 233.97 (-0.77%)
United Therapeutics: Q3 Earnings Snapshot

United Therapeutics: Q3 Earnings Snapshot

UTHR : 233.97 (-0.77%)
Markets Today: Stocks Fall as Fitch Cuts its U.S. Debt Rating

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’...

ESM24 : 5,208.75 (-0.12%)
NQM24 : 18,186.75 (-0.25%)
GNRC : 111.91 (+0.03%)
PINS : 33.98 (-0.61%)
SBUX : 91.01 (+0.99%)
CCL : 16.19 (-0.43%)
EA : 132.48 (-1.33%)
CWH : 25.21 (-2.59%)
NCLH : 19.65 (+1.29%)
VFC : 14.39 (-2.64%)
CVS : 77.57 (+0.22%)
ELF : 196.86 (-1.26%)
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 233.97 (-0.77%)
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

DNLI : 20.09 (-0.20%)
RARE : 46.59 (-1.65%)
SRPT : 123.97 (+0.75%)
PFE : 27.72 (-0.79%)
EXEL : 23.17 (+0.83%)
MRNA : 104.26 (+0.39%)
UTHR : 233.97 (-0.77%)
BIIB : 219.40 (+0.04%)
SNY : 47.83 (-0.95%)
LLY : 762.66 (+1.13%)
Here's What Key Metrics Tell Us About United Therapeutics (UTHR) Q1 Earnings

The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street...

UTHR : 233.97 (-0.77%)
United Therapeutics (UTHR) Q1 Earnings Beat Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of 11.72% and 1.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

UTHR : 233.97 (-0.77%)
ONCT : 7.80 (-2.74%)
United Therapeutics: Q1 Earnings Snapshot

United Therapeutics: Q1 Earnings Snapshot

UTHR : 233.97 (-0.77%)
United Therapeutics Corporation Reports First Quarter 2023 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2023. Total revenues in the first quarter of 2023 grew...

UTHR : 233.97 (-0.77%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 233.97 (-0.77%)
PCRX : 29.29 (-0.41%)
AMRN : 0.8370 (-2.55%)
CORT : 24.31 (+4.65%)
IONS : 42.03 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 244.92
2nd Resistance Point 240.96
1st Resistance Point 237.46
Last Price 233.97
1st Support Level 230.01
2nd Support Level 226.05
3rd Support Level 222.55

See More

52-Week High 261.54
Fibonacci 61.8% 239.73
Last Price 233.97
Fibonacci 50% 232.99
Fibonacci 38.2% 226.25
52-Week Low 204.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar